| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Feb―04 |
Molecular detection and identification of fungal pathogens infections occurring in COVID-19 recovered patients |
Dhanurekha Lakshmipathy, Anand Appakudal Ramaswamy, Hema Raja Pushpam Maharajan, Revathy Menon Anand, Aishwariya Thangam, Ranjith Kumar Santharaj |
| 2 |
[GO] |
2023―Feb―02 |
An algorithm to estimate the real time secondary infections in sub-urban bus travel: COVID-19 epidemic experience at Chennai Metropolitan city India |
Ganesh Ram Arumugam, Bakiya Ambikapathy, Kamalanand Krishnamurthy, Ashwani Kumar, Lourduraj De Britto |
| 3 |
[GO] |
2022―Nov―10 |
SARS-CoV-2 variants of concerns in animals: An unmonitored rising health threat |
AbdulRahman A. Saied, Asmaa A. Metwally |
| 4 |
[GO] |
2022―Oct―25 |
Direct, indirect, post-infection damages induced by coronavirus in the human body: an overview |
Sivan Padma Priya, P. M. Sunil, Sudhir Varma, Carel Brigi, Mohammad Faruq Abd Rachman Isnadi, J. A. Jayalal, et al. (+4) R. Arunkumar Shadamarshan, S. Suresh Kumar, Neela Vasantha Kumari, Rishi P. R. Kumar |
| 5 |
[GO] |
2022―Aug―13 |
Potential factors influencing COVID-19 vaccine acceptance and hesitancy among Bangladeshi people: a cross-sectional study |
Debendra Nath Roy, Md. Mohabbot Hossen, Nowrin Ferdiousi, Md. Shah Azam |
| 6 |
[GO] |
2022―Aug―05 |
Prediction of infectivity of SARS-CoV-2 virus based on Spike-hACE-2 interaction |
Dwaipayan Chaudhuri, Joyeeta Datta, Satyabrata Majumder, Kalyan Giri |
| 7 |
[GO] |
2022―Aug―05 |
Surface contamination by SARS-CoV2 RNA in dedicated COVID care area of a tertiary care hospital in North India |
Subhabrata Sarkar, Arnab Ghosh, Ritin Mohindra, Linta Thomas, Devender Yadav, Harish Chand Kandpal, et al. (+8) Manisha Biswal, P. V. M. Lakshmi, Vikas Suri, Vipin Koushal, Pankaj Malhotra, R. K. Ratho, G. D. Puri, Mini P. Singh |
| 8 |
[GO] |
2022―Jul―22 |
Growth kinetics of an Indian isolate of highly pathogenic porcine reproductive and respiratory syndrome virus in MARC-145 cells |
Subbiah Kombiah, Dhanapal Senthilkumar, Manoj Kumar, Panickan Sivasankar, Vijendra P. Singh, Katherukamem Rajukumar |
| 9 |
[GO] |
2022―Jun―07 |
Seroprevalence of SARS-CoV-2 infection among frontline police personnel in Mumbai, India |
Shibal Bhartiya, Babasaheb V Tandale, Shailesh D Pawar, Nishant Kumar |
| 10 |
[GO] |
2022―Apr―06 |
Respiratory viral infections other than SARS CoV-2 among the North Indian patients presenting with acute respiratory illness during the first COVID-19 wave |
Monika Sapra, Sangeetha Kirubanandhan, Poonam Kanta, Arnab Ghosh, Kapil Goyal, Mini P. Singh, R. K. Ratho |
| 11 |
[GO] |
2022―Feb―01 |
A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges |
Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, Asma Talukder |
| 12 |
[GO] |
2022―Jan―21 |
Computational screening of potential drugs against COVID-19 disease: the Neuropilin-1 receptor as molecular target |
Hicham Charoute, Zouhair Elkarhat, Lamiae Elkhattabi, Elmostafa El Fahime, Naoual Oukkache, Hassan Rouba, Abdelhamid Barakat |
| 13 |
[GO] |
2021―Nov―05 |
Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2 |
Debadrita Paul, Nibedita Pyne, Santanu Paul |
| 14 |
[GO] |
2021―Oct―25 |
MiR-181a and -b expression in acute lymphoblastic leukemia and its correlation with acute graft-versus-host disease after hematopoietic stem cell transplantation, COVID-19 and torque teno viruses |
Mahdiyar Iravani Saadi, Mani Ramzi, Zahra Hesami, Nadiya kheradmand, Maryam Owjfard, Ehsan Nabi Abdolyousefi, Zahed Karimi |
| 15 |
[GO] |
2021―Sep―24 |
Associated pathogenesis of bladder cancer and SARS-CoV-2 infection: a treatment strategy |
Mukul Kumar Singh, Mayank Jain, Hari Shyam, Pratap Shankar, Vishwajeet Singh |
| 16 |
[GO] |
2021―Sep―21 |
Correction to: Do inflammasome impact COVID-19 severity? |
Maria Beatriz Calado, Crislayne Emilly da Silva Santana, Sergio Crovella |
| 17 |
[GO] |
2021―Sep―20 |
Prospective evaluation of specimen pooling strategy for detection of SARS-CoV-2 using pools of five and six specimens |
Georgios Meletis, Styliani Pappa, Maria Exindari, Georgia Gioula, Evangelia Giosi, Antonios Katsoulas, et al. (+2) Ilias Mavrovouniotis, Anna Papa |
| 18 |
[GO] |
2021―Sep―07 |
Exploration of antigenic determinants in spike glycoprotein of SARS-CoV2 and identification of five salient potential epitopes |
Aditya Agrawal, Rajat Varshney, Mamta Pathak, Shailesh Kumar Patel, Vishal Rai, Sourabh Sulabh, et al. (+4) Rohini Gupta, Khushal Singh Solanki, Ritu Varshney, Ramadevi Nimmanapalli |
| 19 |
[GO] |
2021―Aug―18 |
Diagnostic performance of lung ultrasound compared to CT scan in the diagnosis of pulmonary lesions of COVID-19 induced pneumonia: a preliminary study |
Jafar Roshandel, Sam Alahyari, Mehdi Khazaei, Reyhane Asgari, Yashar Moharamzad, Ehsan Zarei, Morteza Sanei Taheri |
| 20 |
[GO] |
2021―Jul―31 |
Potential drug leads for SARS-CoV2 from phytochemicals of Aerva lanata: a Machine Learning approach |
D. R. Sherin, N. Sharanya, T. K. Manojkumar |
| 21 |
[GO] |
2021―Jul―26 |
Dentistry pathways of coronaviruses transmission: a review |
Zahra Setayesh-Mehr, Mahdiye Poorsargol |
| 22 |
[GO] |
2021―Jul―26 |
Do inflammasome impact COVID-19 severity? |
Maria Beatriz Calado, Crislayne Emilly da Silva Santana, Sergio Crovella |
| 23 |
[GO] |
2021―Jul―26 |
Computational Identification of SARS-CoV-2 Inhibitor in Tinospora cordifolia, Cinnamomum zeylanicum and Myristica fragrans |
Viswajit Mulpuru, Nidhi Mishra |
| 24 |
[GO] |
2021―Jul―22 |
COVID-19 gripped the globe with some unnoticed facts and too many questions |
Awanish Kumar |
| 25 |
[GO] |
2021―Jul―15 |
Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach |
Swetha Pulakuntla, Kiran Bharat Lokhande, Pannuru Padmavathi, Meena Pal, Kakumani Venkateswara Swamy, Jayashree Sadasivam, et al. (+3) Shri Abhiav Singh, Sree Latha Aramgam, Vaddi Damodara Reddy |
| 26 |
[GO] |
2021―Jul―15 |
Prospects for controlling future pandemics of SARS in highlights of SARS-CoV-2 |
Buddha Bahadur Basnet, Rajesh Basnet, Raju Panday |
| 27 |
[GO] |
2021―Jul―13 |
A theoretical strategy for acceleration of human immune response against SARS-CoV-2: a fusion protein harboring virus-binding and pre-exposed antigen domains |
Reza Rahmani, Neda Eivazi, Maliheh Paknejad, Mahdi Aminian |
| 28 |
[GO] |
2021―Jul―01 |
Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (Mpro) |
Misbaudeen Abdul-Hammed, Ibrahim Olaide Adedotun, Victoria Adeola Falade, Adewusi John Adepoju, Sabitu Babatunde Olasupo, Modinat Wuraola Akinboade |
| 29 |
[GO] |
2021―Jun―25 |
Attitude and associated factors of COVID-19 vaccine acceptance among health professionals in Debre Tabor Comprehensive Specialized Hospital, North Central Ethiopia; 2021: cross-sectional study |
Yewlsew Fentie Alle, Keder Essa Oumer |
| 30 |
[GO] |
2021―Jun―24 |
Efficacy of phytochemicals as immunomodulators in managing COVID-19: a comprehensive view |
Sonali Bhattacharya, Sudipta Majumdar Nee Paul |
| 31 |
[GO] |
2021―Jun―24 |
Why Is Hormone Therapy Successful Strategy Against Coronavirus-19? |
Gholamreza Asadikaram, Mohammad Kazemi Arababadi |
| 32 |
[GO] |
2021―Jun―23 |
In vitro antiviral activities of ethanol and aqueous extracts of Vietnamese traditional medicinal plants against Porcine Epidemic Diarrhea virus: a coronavirus family member |
Thi Bich Ngoc Trinh, Diep Hong Le, Thanh Thi Kim Nguyen, Van Tam Nguyen, Minh Hong Nguyen, Marc Muller, et al. (+3) Hai The Pham, Van Phan Le, Thao Kim Nu Nguyen |
| 33 |
[GO] |
2021―Jun―09 |
SARS-Cov2: a meta-analysis of symptom distribution by continent in 7310 adult COVID-19 infected patients |
Hitesh Singhavi, Ameya Pai, Manish Mair, Jinesh Singhavi, Prachi Gandhi, Andrew Baker, et al. (+3) Sudip Das, Sanjeev Kumar, Peter Conboy |
| 34 |
[GO] |
2021―Jun―05 |
Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s) |
Swaraj Mohanty, Subhojit Paul, Yasmin Ahmad |
| 35 |
[GO] |
2021―Jun―04 |
Is there any role of intermittent fasting in the prevention and improving clinical outcomes of COVID-19?: intersection between inflammation, mTOR pathway, autophagy and calorie restriction |
Martin Gnoni, Renato Beas, Raúl Vásquez-Garagatti |
| 36 |
[GO] |
2021―Jun―03 |
Assessment of nitric oxide (NO) potential to mitigate COVID-19 severity |
Swati Srivastava, Iti Garg, Anju A. Hembrom, Bhuvnesh Kumar |
| 37 |
[GO] |
2021―May―25 |
The potential impact of the COVID-19 pandemic on antimicrobial resistance and antibiotic stewardship |
Supram Hosuru Subramanya, Daniel M. Czyż, Krishna Prasad Acharya, Hilary Humphreys |
| 38 |
[GO] |
2021―May―05 |
Exploring status of emergency drugs and vaccine development in Covid-19 pandemic: an update |
Alok Sharma, Suhail Ahmed, Jasleen Kaur, Rakesh Chawla, Chandrababu Rejeeth |
| 39 |
[GO] |
2021―May―04 |
Mechanism involved in the pathogenesis and immune response against SARS-CoV-2 infection |
Utkarsha Sahu, Debasis Biswas, Anirudh Kumar Singh, Prashant Khare |
| 40 |
[GO] |
2021―May―03 |
Detection of SARS-CoV-2 infection by RT-PCR test: factors influencing interpretation of results |
Kiran Munne, Venkanna Bhanothu, Vikrant Bhor, Vainav Patel, Smita D. Mahale, Shailesh Pande |
| 41 |
[GO] |
2021―Apr―29 |
Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors |
Mahmoud Hamed, Mahmoud El-Hasab, Fotouh R. Mansour |
| 42 |
[GO] |
2021―Apr―29 |
A new emerging pandemic of severe fever with thrombocytopenia syndrome (SFTS) |
Divya Sharma, Mohit Kamthania |
| 43 |
[GO] |
2021―Apr―22 |
SARS-CoV-2 aerosol and droplets: an overview |
Udaykumar Ranga |
| 44 |
[GO] |
2021―Apr―10 |
Molecular docking and ADMET studies of Allium cepa, Azadirachta indica and Xylopia aethiopica isolates as potential anti-viral drugs for Covid-19 |
Peter Ifeoluwa Adegbola, Banjo Semire, Olumide Samuel Fadahunsi, Aanuoluwa Eunice Adegoke |
| 45 |
[GO] |
2021―Apr―07 |
COVID-19 infection in a HIV positive health care worker: first case report from a tertiary care hospital of North India |
Ritin Mohindra, Poonam Kanta, Pradakshana Porchezhian, Kapil Goyal, Vikas Suri, Mini P. Singh, et al. (+2) Lakshmi PVM, Ashish Bhalla |
| 46 |
[GO] |
2021―Apr―05 |
In silico approach to understand the epigenetic mechanism of SARS-CoV-2 and its impact on the environment |
Sahar Qazi, Kayenat Sheikh, Khalid Raza |
| 47 |
[GO] |
2021―Mar―22 |
Vaccines and drugs under clinical trials for prevention and treatment of COVID-19 |
Umesh C. S. Yadav |
| 48 |
[GO] |
2021―Mar―20 |
Computationally approached inhibition potential of Tinospora cordifolia towards COVID-19 targets |
Sushovan Jena, Punnagai Munusami, Balamurali MM, Kaushik Chanda |
| 49 |
[GO] |
2021―Mar―18 |
A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery |
U. Rutwick Surya, N. Praveen |
| 50 |
[GO] |
2021―Mar―17 |
Respiratory delivery of favipiravir-tocilizumab combination through mucoadhesive protein-lipidic nanovesicles: prospective therapeutics against COVID-19 |
Vikram Thakur, Radha Kanta Ratho, Jiban Jyoti Panda |
| 51 |
[GO] |
2021―Mar―10 |
Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus |
Ritu Ghildiyal, Reema Gabrani |
| 52 |
[GO] |
2021―Mar―04 |
Evaluation of diagnostic accuracy of developed rapid SARS-COV-2 IgG antibody test kit using novel diluent system |
Vani Maya, Jyothi Embekkat Kaviyil, Dinoop Koral Ponnambath, Renjith P. Nair, Anugya Bhatt, Rajendra Pilankatta, et al. (+4) Lathika Valliyot, Ranjeet Dungdung, Ramdas Athikkal Veettil, Manoj Gopi |
| 53 |
[GO] |
2021―Feb―22 |
SARS-CoV-2: phylogenetic origins, pathogenesis, modes of transmission, and the potential role of nanotechnology |
Amit Kumar Sahu, M. Sreepadmanabh, Mahendra Rai, Ajit Chande |
| 54 |
[GO] |
2021―Feb―18 |
Cognitive assessment in asymptomatic COVID-19 subjects |
Sridhar Amalakanti, Kesava Venkata Raman Arepalli, Jyothi Priya Jillella |
| 55 |
[GO] |
2021―Jan―28 |
In silico virtual screening-based study of nutraceuticals predicts the therapeutic potentials of folic acid and its derivatives against COVID-19 |
Vipul Kumar, Sudhakar Kancharla, Manoj Kumar Jena |
| 56 |
[GO] |
2020―Dec―07 |
Molecular characterisation of porcine reproductive and respiratory syndrome virus from pigs in Kerala |
G. Chaithra, Chintu Ravishankar, Stephy Rose Sebastian, R. Rajasekhar, R. Anoopraj, Binu K. Mani, et al. (+5) K. Sumod, Chandankar Vaidehi Deorao, G. Logeshwaran, D. Nandhakumar, Koshy John |
| 57 |
[GO] |
2020―Dec―05 |
Chasing COVID-19 through SARS-CoV-2 spike glycoprotein |
Shailendra K. Saxena, Swatantra Kumar, Preeti Baxi, Nishant Srivastava, Bipin Puri, R. K. Ratho |
| 58 |
[GO] |
2020―Dec―02 |
Selection of animal models for COVID-19 research |
Suresh Kumar, Pardeep Kumar Yadav, Ramesh Srinivasan, Nagarajan Perumal |
| 59 |
[GO] |
2020―Nov―11 |
Combinatorial therapeutic trial plans for COVID-19 treatment armed up with antiviral, antiparasitic, cell-entry inhibitor, and immune-boosters |
Nabanita Roy Chattopadhyay, Koustav Chatterjee, Antara Banerjee, Tathagata Choudhuri |
| 60 |
[GO] |
2020―Nov―11 |
Structure-guided discovery approach identifies potential lead compounds targeting Mpro of SARS-CoV-2 |
Mohcine Elmessaoudi-Idrissi, Kyoko Tsukiyama-Kohara, Jalal Nourlil, Anass Kettani, Marc P. Windisch, Michinori Kohara, et al. (+4) Yashpal Singh Malik, Kuldeep Dhama, Soumaya Benjelloun, Sayeh Ezzikouri |
| 61 |
[GO] |
2020―Oct―16 |
SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations |
Sarayu Krishnamoorthy, Basudev Swain, R. S. Verma, Sachin S. Gunthe |
| 62 |
[GO] |
2020―Oct―16 |
2019-nCoV: a worldwide concern and facts |
Rajani Sharma, Gargi Akhoury |
| 63 |
[GO] |
2020―Sep―11 |
SARS-CoV-2 infection: physiological and environmental gift factors at high altitude |
Swati Srivastava, Iti Garg, Anju Bansal, Bhuvnesh Kumar |
| 64 |
[GO] |
2020―Aug―08 |
Ramping up of SARS CoV-2 testing for the diagnosis of COVID-19 to better manage the next phase of pandemic and reduce the mortality in India |
Senthilkumar Natesan, Ragini Bhatia, Aarthi Sundararajan, Kuldeep Dhama, Yashpal S. Malik, Kranti Vora |
| 65 |
[GO] |
2020―Jun―26 |
The global emergence of severe acute respiratory syndrome coronavirus 2 in human |
Bikash Mandal |
| 66 |
[GO] |
2020―Jun―23 |
Emerging coronavirus diseases and future perspectives |
Shireen Akhter, Shahzeen Akhtar |
| 67 |
[GO] |
2020―Jun―22 |
Decoding the global outbreak of COVID-19: the nature is behind the scene |
Piyanki Das, Tathagata Choudhuri |
| 68 |
[GO] |
2020―Jun―13 |
COVID-19 diagnostic approaches: different roads to the same destination |
Ramesh Kumar, Suman Nagpal, Samander Kaushik, Sanjay Mendiratta |
| 69 |
[GO] |
2020―Jun―11 |
Relevance of SARS-CoV-2 in food safety and food hygiene: potential preventive measures, suggestions and nanotechnological approaches |
Zafer Ceylan, Raciye Meral, Turgay Cetinkaya |
| 70 |
[GO] |
2020―Jun―11 |
Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era |
Dinesh Kumar Rajendran, Varthini Rajagopal, S. Alagumanian, T. Santhosh Kumar, S. P. Sathiya Prabhakaran, Dharun Kasilingam |
| 71 |
[GO] |
2020―Jun―10 |
Statistical analysis and visualization of the potential cases of pandemic coronavirus |
R. Muthusami, K. Saritha |
| 72 |
[GO] |
2020―Jun―05 |
Inanimate surfaces as potential source of 2019-nCoV spread and their disinfection with biocidal agents |
Muhammad Zeeshan Akram |
| 73 |
[GO] |
2020―May―24 |
Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor |
Vimal K. Maurya, Swatantra Kumar, Anil K. Prasad, Madan L. B. Bhatt, Shailendra K. Saxena |
| 74 |
[GO] |
2020―May―22 |
What we know about 2019-nCoV in Iran in the early stage? |
Milad Dodangeh, Masoud Dodangeh, Mohammadamin Joulani, Azinmehr Elahian Boroujeni |
| 75 |
[GO] |
2020―May―12 |
Human coronaviruses with emphasis on the COVID-19 outbreak |
Saraj Bahadur, Wenxing Long, Muhammad Shuaib |
| 76 |
[GO] |
2020―May―06 |
The dipeptidyl peptidase-4 expression in some MERS-CoV naturally infected dromedary camels in Saudi Arabia 2018-2019 |
Abdelmohsen Alnaeem, Samy Kasem, Ibrahim Qasim, Ali Al-Doweriej, Mohamed Refaat, Abdulkareem Al-Shabebi, Maged Gomaa Hemida |
| 77 |
[GO] |
2020―May―04 |
The Indian perspective of COVID-19 outbreak |
Samander Kaushik, Sulochana Kaushik, Yashika Sharma, Ramesh Kumar, Jaya Parkash Yadav |
| 78 |
[GO] |
2020―May―04 |
The molecular biology of intracellular events during Coronavirus infection cycle |
Juhi Jain, Sharad Gaur, Yash Chaudhary, Rajeev Kaul |
| 79 |
[GO] |
2020―May―02 |
Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock |
Dipti Mothay, K. V. Ramesh |
| 80 |
[GO] |
2020―Apr―20 |
One month of the novel coronavirus 2019 outbreak: Is it still a threat? |
Apu Chowdhury, Nabila Jahan, Sicen Wang |
| 81 |
[GO] |
2020―Apr―20 |
Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives |
Khadga Raj, Anirban Ghosh, Shamsher Singh |
| 82 |
[GO] |
2020―Apr―20 |
Coronavirus threat to Indian population: risk factors, transmission dynamics and preparedness to prevent the spread of the virus |
Dibyakanti Mandal |
| 83 |
[GO] |
2020―Apr―18 |
Recent apprise on coronavirus and its terrible insinuations |
Sankha Bhattacharya, Priyanka Sharma, Harshita Mathur, Haamid Rasheed, Saranjit Singh, Geeta Rajput, et al. (+3) Suyash Agnihotri, Puneet Nirmal, Sukhbir Kaur |
| 84 |
[GO] |
2020―Apr―08 |
Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020 |
Arshi Islam, Anwar Ahmed, Irshad H. Naqvi, Shama Parveen |
| 85 |
[GO] |
2020―Mar―05 |
Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV) |
Swatantra Kumar, Vimal K. Maurya, Anil K. Prasad, Madan L. B. Bhatt, Shailendra K. Saxena |
